EYPT earnings: real EPS beat/miss history, analyst consensus Buy, P/E -3.62. Updated 2026-07-23.
EyePoint Pharmaceuticals (EYPT) Research Hub
EyePoint Pharmaceuticals (EYPT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 4.23 USD (-2.53%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.62, market cap 1.05B. This hub links to the full technical, earnings and options research available for EYPT.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 4.23 USD (-2.53%) |
| 52-week range | 3.95 USD – 15.38 USD |
| Trend regime | Range |
| 14-day RSI | 14.5 (Oversold) |
| Trailing P/E | -3.62 |
| Market cap | 1.05B |
| Dividend yield | 0.00% |
Available research for EYPT
Covered Call on EYPT: how it works, illustrative setup around the real 4.23 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on EYPT: how it works, illustrative setup around the real 4.23 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on EYPT: how it works, illustrative setup around the real 4.23 USD price, max profit/loss, breakeven and when to use it. Educational.
EYPT technical analysis: range, last 4.23 USD, RSI 14.5, 52w range 3.95 USD–15.38 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is EYPT in?
EyePoint Pharmaceuticals (EYPT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is EYPT in an uptrend or downtrend?
As of 2026-09-11, EYPT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is EYPT's trailing P/E ratio?
EYPT's trailing P/E is -3.62, with a market cap of 1.05B. See the earnings research page for full valuation detail.